Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator T. W. Kurtz OriginalPaper Pages: s9 - s16
The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction G. Mancia OriginalPaper Pages: s17 - s25
Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers U. KintscherT. Unger OriginalPaper Pages: s26 - s32
Renin–angiotensin–aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers? L. M. Ruilope OriginalPaper Pages: s33 - s41
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study* A. H. Barnett OriginalPaper Pages: s42 - s49
